← Leaderboards
Olivier Elemento
Weill Medical Coll Of Cornell Univ
$10,592,678
Attributed
$37,220,340
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.4M · FY2015–25$10M$7.5M$5M$2.5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,220,340 · 13
By mechanism
OT2$18,141,199 · 2
R01$6,219,173 · 4
U24$4,353,475 · 2
UH3$2,932,940 · 1
UG3$2,054,037 · 1
P01$1,893,749 · 1
Top collaborators
- Nasser Khaled Altorki9 shared
- Alain C Borczuk9 shared
- Timothy E Mcgraw9 shared
- Vivek Mittal9 shared
- Paraskevi Giannakakou6 shared
- Manish A Shah6 shared
- Wayne Tam6 shared
- Nicolas Robine5 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Nasser Khaled Altorki$2,970,612
- Vivek Mittal$10,850,597
- Alain C Borczuk$997,395
- Cora Sternberg$662,585
- Nicolas Robine$2,189,736
Others in their field
Top investigators on “Transcriptome Sequencing”
- Stacey Gabriel · Massachusetts Institute Of Technology$136,250,146
- Hongkui Zeng · Allen Institute$113,949,516
- Ed Lein · Allen Institute$90,043,218
- Eric S Lander · Whitehead Institute For Biomedical Res$77,457,964
- Richard A Gibbs · Baylor College Of Medicine$55,759,987
- Nenad Sestan · Yale University$55,663,111
Research focus
Transcriptome SequencingSamplingTumorMutationCellsPrecision MedicineExome SequencingBaseResearch PersonnelGenomicsPathway InteractionsCohortGenesResponsePublishingMolecularImmuneMedicineInstitutesPharmaceutical PreparationsPublicationsExperimental StudyVariantPhenotype
Grant awards (52)
Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before$4,660,942
OT2 · FY2025 · OD
Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before$4,215,002
OT2 · FY2025 · OD
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$380,595
U24 · FY2025 · CA · contact PI
Data Management and Analysis Core$131,339
U19 · FY2025 · AI · contact PI
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$385,514
U24 · FY2024 · CA · contact PI
SAMBAI: Societal, Ancestry and Molecular Biology Analyses of Inequalities$145,921
OT2 · FY2024 · CA · contact PI
Data Management and Analysis Core$110,787
U19 · FY2024 · AI · contact PI
Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before$5,302,032
OT2 · FY2023 · OD
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$805,881
UH3 · FY2023 · CA
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$397,689
U24 · FY2023 · CA · contact PI
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$234,178
UH3 · FY2023 · CA
Data Management and Analysis Core$135,600
U19 · FY2023 · AI · contact PI
Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before$3,817,302
OT2 · FY2022 · OD
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$808,655
UH3 · FY2022 · CA
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.$501,039
R01 · FY2022 · CA
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$397,689
U24 · FY2022 · CA · contact PI
Core C: Genomics & Bioinformatics Core$366,926
P01 · FY2022 · CA · contact PI
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$238,958
UH3 · FY2022 · CA
Data Management and Analysis Core$147,304
U19 · FY2022 · AI · contact PI
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$845,268
UH3 · FY2021 · CA
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.$471,756
R01 · FY2021 · CA
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$426,268
U24 · FY2021 · CA · contact PI
Core C: Genomics & Bioinformatics Core$375,631
P01 · FY2021 · CA · contact PI
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$249,999
UG3 · FY2021 · CA
Computational/Biostatistical Core$215,140
P50 · FY2021 · CA · contact PI
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$836,730
UG3 · FY2020 · CA
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.$504,230
R01 · FY2020 · CA
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$472,504
U24 · FY2020 · CA · contact PI
Core C: Genomics & Bioinformatics Core$381,492
P01 · FY2020 · CA · contact PI
Computational/Biostatistical Core$219,767
P50 · FY2020 · CA · contact PI
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$130,578
UG3 · FY2020 · CA
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore$61,478
R01 · FY2020 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$836,730
UG3 · FY2019 · CA
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.$489,103
R01 · FY2019 · CA
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$458,329
U24 · FY2019 · CA · contact PI
The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma$445,962
R01 · FY2019 · CA · contact PI
Core C: Genomics & Bioinformatics Core$375,784
P01 · FY2019 · CA · contact PI
Computational/Biostatistical Core$215,140
P50 · FY2019 · CA · contact PI
COHESIN REGULATORY PROTEINS AND CHROMOSOMAL ARCHITECTURE IN NORMAL AND MALIGNANT B-CELLS$540,539
R01 · FY2018 · CA
The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma$530,098
R01 · FY2018 · CA · contact PI
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.$504,230
R01 · FY2018 · CA
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$472,504
U24 · FY2018 · CA · contact PI
Core C: Genomics & Bioinformatics Core$393,916
P01 · FY2018 · CA · contact PI
Computational/Biostatistical Core$231,332
P50 · FY2018 · CA · contact PI
The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma$530,098
R01 · FY2017 · CA · contact PI
Immune cell gene expression and predictive models in CFS$522,142
R01 · FY2017 · AI · contact PI
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$472,504
U24 · FY2017 · CA · contact PI
Computational/Biostatistical Core$219,358
P50 · FY2017 · CA · contact PI
The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma$530,098
R01 · FY2016 · CA · contact PI
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$489,879
U24 · FY2016 · CA · contact PI
The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma (Administrative Supplement)$58,302
R01 · FY2016 · CA · contact PI
The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma$530,098
R01 · FY2015 · CA · contact PI